References
- S.A.GamageD.P.FiggittS.J.WojcikR.K.RalphA.RansijnJ.MauelV.YardleyD.SnowdonS.L.CroftandW.A.DennyJ. Med. Chem.40199726342642
- V.NadarajS.T.SelviS.MohanEur. J. Med. Chem.4432009976980
- S.A.GamageD.P.FiggittS.J.Wojciket alJ. Med. Chem.4016199726342642
- B.F.DickensW.B.WeglickiP.A.BoehmeT.I.MakJ. Mol. Cell. Cardiol.3422002129137
- S.A.GamageN.TepsiriP.Wilairatet alJ. Med. Chem.3710199414861494
- Y.L.ChenC.M.LuI.L.ChenL.T.TsaoJ.P.WangJ. Med. Chem.4521200246894694
- S.M.SondhiM.JoharN.SinghalR.ShuklaR.RaghubirS.G.DastidarIndian J. Chem. B4112200226592666
- I.AntoninCurr. Med. Chem.9200217011716
- M.DemeunynckA.CharmantrayA.MartelliCurr. Pharm. Des.7200117031724
- K.A.WerbovetzP.G.SpoorsR.D.PearsonT.L.MacDonaldMol. Biochem. Parasitol.651994110
- C.S.RouvierJ.M.BarretC.M.FarrellD.SharplesB.T.HillJ.BarbeEur. J. Med. Chem.3912200410291038
- K.RastogiJ.Y.ChangW.Y.Panet alJ. Med. Chem.4520200244854493
- K.M.ChenY.W.SunY.W.TangZ.Y.SunC.H.KwonMol. Pharm.222005118128
- A.AlbertThe Acridines2nd ed.1966Edward ArnoldLondonA.AlbertSelective Toxicity7th ed.1985Chapman & HallLondon
- M.KimuraI.OkabayashiFormation and molecular structure of the novel acridine substituted uracil derivativesJ. Heterocycl. Chem.231986965
- M.DemeunynckF.CharmantrayA.MartelliInterest of acridine derivatives in the anticancer chemotherapyCurr. Pharm. Des.720011703172410.2174/1381612013397131
- M.K.GoftarN.A.RayeniN.MohamadiSpectroscopic studies on the interaction between acridinespermine conjugate with DNAInt. J. Biosci.542014273310.12692/ijb/5.4.27-33
- R.F.LynnetteA.D.WilliamThe genetic toxicology of acridinesMutatton Res.2581991123160
- R.B.SilvermanM.W.HolladayDNA-Interactive Agents, the Organic Chemistry of Drug Design and Drug Action, Chapter 6201410.1016/B978-0-12-382030-3.00006-4
- K.DrlicaR.J.FrancoInhibitors of DNA topoisomerasesBiochemistry277198822532259
- M.J.WaringAnnu. Rev. Biochem.5015901981
- E.M.NelsonK.M.TeweyL.F.LiuProc. Natl. Acad. Sci. U. S. A.8119841361
- M.J.WaringDNA-binding characteristics of acridinylmethanesulfonanilide drugs: comparison with antitumor propertiesEur. J. Cancer1219769951001
- M.KimuraI.OkabayashiJ. Heterocycl. Chem.2331986965967
- M.KimuraA.KatoI.OkabayashiJ. Heterocycl. Chem.29119927380
- M.KimuraQuenching of ethidium-DNA fluorescence by novel acridines with antitumor activitiesYakugaku Zasshi112121992914918
- C.B.BruceA.D.WilliamJ.A.GrahamF.C.BruceJ. Med. Chem.241981170177
- B.C.BaguleyW.A.DennyG.J.AtwellB.F.CainPotential antitumor agents. Quantitative relationships between DNA binding and molecular structure for 9-anflinoacridines substituted in the anilino ringJ. Med. Chem.341981107177
- C.AdamoV.BaroneJ. Chem. Phys. Lett.3302000152M.ParacS.GrimmeJ. Phys. Chem.10620036844Y.YamaguchiS.YokoyamaS.MashikoJ. Chem. Phys.11620026541
- L.BeckerK.HinrichsU.FinkeA new algorithm for computing joins with grid filesProc. of the 9th International Conference on Data EngineeringVienna, Austria1993190197S.J.LeeJ.FinkA.B.BalantekinM.R.StrayerA.S.UmarP.G.ReinhardJ.A.MaruhnW.GreinerPhys. Rev. Lett.601988163
- S.ChtitaM.GhamaliM.LarifA.AdadR.HmammouchiM.BouachrineT.LakhlifiPrediction of biological activity of imidazo[1, 2-a] pyrazine derivatives by combining DFT and QSAR resultsIJIRSET21220137962
- U.SakarR.ParthasarathiV.SubramanianP.K.ChattarajiToxicity analysis of polychlorinated dibenzofurans through globalJ. Mol. IECMD Des.2004124
- XLSTAT 2009 Add-in software (XLSTAT Company). www.xlstat.com.
- S.ChtitaM.LarifM.GhamaliM.BouachrineT.LakhlifiDFT-based QSAR Studies of MK801 derivatives for non competitive antagonists of NMDA using electronic and topological descriptorsJ. Taibah Univ. Sci.201410.1016/j.jtusci.2014.10.006